Skip to main content
AYTU
NASDAQ Life Sciences

Aytu Tops Q1 Estimates as EXXUA Prescriptions Jump 33% Sequentially

Tom Rudovsky · Reported by Reuters
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1.82
Mkt Cap
$19.78M
52W Low
$1.75
52W High
$3.065
52W Position info
4.0% above low
Off High info
41% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

AYTU is trading near its 52-week low of $1.75 (4.0% above the low).

Summary

Aytu reported fiscal Q1 revenue of $14.84M against a $13.27M consensus, with the adjusted EBITDA loss narrowing to $2.60M versus the $2.93M loss analysts expected. EXXUA drove the beat, with prescriptions up 33% sequentially, while the ADHD portfolio slipped on reduced promotional emphasis and generic competition and the pediatric portfolio improved on better payer mix and lower returns. Net loss was $3.88M and gross profit $9.44M. The company gave no guidance for future quarters or the full year. The results land alongside the announced Rosemont Pharmaceuticals acquisition at $2.70 a share in cash, which caps the trading relevance of the beat — the stock is now tied to deal completion rather than standalone earnings momentum.

At the time of this announcement, AYTU was trading at $1.82 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $19.8M. The 52-week trading range was $1.75 to $3.07. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

AYTU - Latest Insights

AYTU
Nov 16, 2026, 4:17 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.82
Real-time Price: $2.63 info
Change: +$0.810 (+45%) info
Market Cap: $19.78M info
AYTU
Nov 16, 2026, 4:01 PM EST
Source: ACCESS Newswire
Importance Score:
9
Price at Filing: $1.82
Real-time Price: $2.63 info
Change: +$0.810 (+45%) info
Market Cap: $19.78M info
AYTU
Sep 22, 2026, 4:14 PM EDT
Filing Type: 10-K
Importance Score:
7
Price at Filing: $2.34
Real-time Price: $2.63 info
Change: +$0.290 (+12%) info
Market Cap: $19.78M info
AYTU
Sep 22, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.26
Real-time Price: $2.63 info
Change: +$0.3699 (+16%) info
Market Cap: $19.78M info
AYTU
Sep 22, 2026, 4:05 PM EDT
Source: ACCESS Newswire
Importance Score:
7
Price at Filing: $2.35
Real-time Price: $2.63 info
Change: +$0.280 (+12%) info
Market Cap: $19.78M info